Together, we can transform the future of cancer care.
Tracking early stage breast cancer with ultrasensitive ctDNA
Information for patients with breast cancer
Monitoring therapy response with ultrasensitive ctDNA across cancer types
Ultrasensitive ctDNA detection in early-stage lung cancer
Personalis is transforming the development of next-generation therapies.
Designed to support the entire spectrum of precision oncology, Personalis is paving the way for the development and commercialization of new cancer therapies. From improved processes, to advanced assays and analytics, the technology we pioneer is helping our biopharma partners harness the power of genomic data, making personalized cancer treatment a reality for all patients.
